S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

West Pharmaceutical Services Stock Forecast, Price & News

+2.97 (+1.07 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $280.65
50-Day Range
MA: $294.84
52-Week Range
Now: $280.65
Volume668,200 shs
Average Volume532,216 shs
Market Capitalization$20.80 billion
P/E Ratio74.05
Dividend Yield0.24%
West Pharmaceutical Services, Inc. manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, Ireland, France, Other European countries, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, and washing and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was founded in 1923 and is headquartered in Exton, Pennsylvania.
West Pharmaceutical Services logo

Industry, Sector and Symbol

Industry Fabricated rubber products, not elsewhere classified
Sub-IndustryHealth Care Supplies
Year Founded1923



Sales & Book Value

Annual Sales$1.84 billion
Cash Flow$4.61 per share
Book Value$21.26 per share


Net Income$241.70 million


Market Cap$20.80 billion
Next Earnings Date4/22/2021 (Estimated)


Overall MarketRank

2.12 out of 5 stars

Medical Sector

39th out of 1,962 stocks

Fabricated Rubber Products, Not Elsewhere Classified Industry

2nd out of 6 stocks

Analyst Opinion: 2.3Community Rank: 2.0Dividend Strength: 3.3Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
+2.97 (+1.07 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WST News and Ratings via Email

Sign-up to receive the latest news and ratings for WST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

West Pharmaceutical Services (NYSE:WST) Frequently Asked Questions

Is West Pharmaceutical Services a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" West Pharmaceutical Services stock.
View analyst ratings for West Pharmaceutical Services
or view top-rated stocks.

What stocks does MarketBeat like better than West Pharmaceutical Services?

Wall Street analysts have given West Pharmaceutical Services a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but West Pharmaceutical Services wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting West Pharmaceutical Services?

West Pharmaceutical Services saw a drop in short interest during the month of February. As of February 12th, there was short interest totaling 668,400 shares, a drop of 20.9% from the January 28th total of 845,500 shares. Based on an average daily trading volume, of 491,700 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.9% of the shares of the stock are sold short.
View West Pharmaceutical Services' Short Interest

When is West Pharmaceutical Services' next earnings date?

West Pharmaceutical Services is scheduled to release its next quarterly earnings announcement on Thursday, April 22nd 2021.
View our earnings forecast for West Pharmaceutical Services

How were West Pharmaceutical Services' earnings last quarter?

West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings results on Thursday, February, 18th. The medical instruments supplier reported $1.34 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.13 by $0.21. West Pharmaceutical Services had a trailing twelve-month return on equity of 19.01% and a net margin of 14.69%.
View West Pharmaceutical Services' earnings history

How has West Pharmaceutical Services' stock price been impacted by COVID-19 (Coronavirus)?

West Pharmaceutical Services' stock was trading at $147.83 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, WST stock has increased by 89.8% and is now trading at $280.65.
View which stocks have been most impacted by COVID-19

How often does West Pharmaceutical Services pay dividends? What is the dividend yield for West Pharmaceutical Services?

West Pharmaceutical Services announced a quarterly dividend on Wednesday, February 24th. Investors of record on Wednesday, April 21st will be given a dividend of $0.17 per share on Wednesday, May 5th. This represents a $0.68 annualized dividend and a dividend yield of 0.24%. The ex-dividend date of this dividend is Tuesday, April 20th.
View West Pharmaceutical Services' dividend history

Is West Pharmaceutical Services a good dividend stock?

West Pharmaceutical Services pays an annual dividend of $0.68 per share and currently has a dividend yield of 0.24%. West Pharmaceutical Services has been increasing its dividend for 25 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of West Pharmaceutical Services is 20.99%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, West Pharmaceutical Services will have a dividend payout ratio of 14.56% next year. This indicates that West Pharmaceutical Services will be able to sustain or increase its dividend.
View West Pharmaceutical Services' dividend history.

What guidance has West Pharmaceutical Services issued on next quarter's earnings?

West Pharmaceutical Services updated its FY 2021 Pre-Market earnings guidance on Thursday, February, 18th. The company provided EPS guidance of 6.00-6.15 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.12. The company issued revenue guidance of $2.5-2.525 billion, compared to the consensus revenue estimate of $2.35 billion.

What price target have analysts set for WST?

3 brokers have issued 12-month price objectives for West Pharmaceutical Services' stock. Their forecasts range from $280.00 to $350.00. On average, they anticipate West Pharmaceutical Services' stock price to reach $310.00 in the next twelve months. This suggests a possible upside of 10.5% from the stock's current price.
View analysts' price targets for West Pharmaceutical Services
or view top-rated stocks among Wall Street analysts.

Who are West Pharmaceutical Services' key executives?

West Pharmaceutical Services' management team includes the following people:
  • Mr. Eric M. Green, Pres, CEO & Director (Age 51, Pay $2.28M)
  • Mr. Bernard J. Birkett, Sr. VP & CFO (Age 52, Pay $1.18M)
  • Mr. David A. Montecalvo, Sr. VP and Chief Operations & Supply Chain Officer (Age 56, Pay $801.65k)
  • Mr. George Lloyd Miller, Special Advisor (Age 66, Pay $835.13k)
  • Mr. Silji Abraham, Chief Digital & Transformation Officer and Sr. VP (Age 49, Pay $796.49k)
  • Mr. Chad R. Winters, VP, Chief Accounting Officer, Principal Accounting Officer & Corp. Controller (Age 43)
  • Mr. Eric Resnick, CTO & VP (Age 57)
  • Dr. Quintin J. Lai C.F.A., Ph.D., VP of Corp. Devel., Strategy & Investor Relations (Age 54)
  • Ms. Kimberly Banks MacKay, Sr. VP, Gen. Counsel & Company Sec. (Age 56)
  • Michele Pelkowski, VP of Global Communications

What is Eric M. Green's approval rating as West Pharmaceutical Services' CEO?

107 employees have rated West Pharmaceutical Services CEO Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among West Pharmaceutical Services' employees. 61.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

Who are some of West Pharmaceutical Services' key competitors?

What other stocks do shareholders of West Pharmaceutical Services own?

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), The Walt Disney (DIS), The Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

What is West Pharmaceutical Services' stock symbol?

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

Who are West Pharmaceutical Services' major shareholders?

West Pharmaceutical Services' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (9.86%), Price T Rowe Associates Inc. MD (6.26%), WCM Investment Management LLC (2.18%), WCM Investment Management LLC (2.18%), Bamco Inc. NY (1.81%) and Artisan Partners Limited Partnership (1.76%). Company insiders that own West Pharmaceutical Services stock include Annette F Favorite, Daniel Malone, David A Montecalvo, George Lloyd Miller, Patrick J Zenner and Silji Abraham.
View institutional ownership trends for West Pharmaceutical Services

Which major investors are selling West Pharmaceutical Services stock?

WST stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Wells Fargo & Company MN, JPMorgan Chase & Co., Panagora Asset Management Inc., Bamco Inc. NY, GW&K Investment Management LLC, Victory Capital Management Inc., and Federated Hermes Inc.. Company insiders that have sold West Pharmaceutical Services company stock in the last year include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, and Silji Abraham.
View insider buying and selling activity for West Pharmaceutical Services
or view top insider-selling stocks.

Which major investors are buying West Pharmaceutical Services stock?

WST stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., WCM Investment Management LLC, WCM Investment Management LLC, Brown Advisory Inc., Price T Rowe Associates Inc. MD, The Manufacturers Life Insurance Company , California Public Employees Retirement System, and Nuveen Asset Management LLC.
View insider buying and selling activity for West Pharmaceutical Services
or or view top insider-buying stocks.

How do I buy shares of West Pharmaceutical Services?

Shares of WST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is West Pharmaceutical Services' stock price today?

One share of WST stock can currently be purchased for approximately $280.65.

How much money does West Pharmaceutical Services make?

West Pharmaceutical Services has a market capitalization of $20.80 billion and generates $1.84 billion in revenue each year. The medical instruments supplier earns $241.70 million in net income (profit) each year or $3.24 on an earnings per share basis.

How many employees does West Pharmaceutical Services have?

West Pharmaceutical Services employs 8,200 workers across the globe.

When was West Pharmaceutical Services founded?

West Pharmaceutical Services was founded in 1923.

What is West Pharmaceutical Services' official website?

The official website for West Pharmaceutical Services is www.westpharma.com.

Where are West Pharmaceutical Services' headquarters?

West Pharmaceutical Services is headquartered at 530 HERMAN O. WEST DRIVE, EXTON PA, 19341.

How can I contact West Pharmaceutical Services?

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The medical instruments supplier can be reached via phone at 610-594-2900 or via email at [email protected]

This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.